Skip to content

Comparison of the safety and efficacy between Canaloplasty ab interno and Gonioscopy-Assisted Transluminal Trabeculotomy on open angle glaucoma:a prospective randomized controlled study

Comparison of the safety and efficacy between Canaloplasty ab interno and Gonioscopy-Assisted Transluminal Trabeculotomy on open angle glaucoma:a prospective randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016933
Enrollment
Unknown
Registered
2018-07-03
Start date
2018-06-25
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

1:ab interno Canaloplasty
2:Gonioscopy-Assisted Transluminal Trabeculotomy

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. patients with primary open angle or juvenile Glaucoma; 2. visual field defects, MD-0.01 to -6.00 or MD-6.01 to-12.00;, 3. the patients aged 18 to 60 years could understand and write the consent independenly before surgery; 4. without prior glaucoma surgery; 5. the patients could be able to complete follow-up.

Exclusion criteria

Exclusion criteria: 1. without interno occular surgery; 2. a history of ocular trauma; 3. with uveitis,retinitis pigmentosa,central retinal artery occlusion,branch retinal artery,cilioretinal artery occlusion,optic neuropathy,maculopathy; 4. corneal opacity; 5. orbital tumor; 6. the disease which can influence the IOP and visual acuity,include thyroid related ophalmopathy,retinal detachment and lens dislocation; 7. serious health issues which could impede the follow-up,include Cardia-cerebrovascular Disease,the disease of lung and kidney ,lung and kidney diseases,terminal cancer; 8. refuse to sign the consent; 9. pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
Intraocular Pressure;

Secondary

MeasureTime frame
medicine;

Countries

China

Contacts

Public ContactWang Ningli

Beijing Tongren Hospital

wningli@vip.163.com+86 13511026669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026